Back

Usefulness of the H2PEF score in the stratification of patients with a diagnosis of heart failure with preserved ejection fraction in primary care

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms 5 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Victoria Cendros

(Spain)

5 More presentations in this session

Presentation thumbnail
Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction
Doctor S. Mukhtarova (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
Doctor S. Mukhtarova (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Impact of HFpEF in pacemaker patients: a closer look at heart failure events and mortality risk
Mrs E. Santos (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Unraveling gender's influence: a detailed analysis of mortality and acute heart failure risk in HFpEF Patients post-pacemaker Implantation
Miss E. Santos (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Cardiopulmonary exercise testing in HFpEF patients - a stress-to-rest ratio analyses
Doctor K. Franz (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Three rules to find them all: clinical risk scores in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
The value of scoring systems in terms of phenogroups in the diagnosis of heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Occurrence of echocardiographic indicators consistent with heart failure with preserved ejection fraction in everyday clinical settings

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources